MOS is dedicated to ensuring you stay informed during the COVID-19 crisis. Click above to find all of the latest resources from ASCO, ASH, COA, HOSS, and important Industry News related to the crisis.
The Mississippi Society of Oncology was formed in 1991 for the purpose ofpromoting the highest professional standards of oncology in Mississippi, to study, research and exchange information, experiences and ideas leading to improvement in oncology and promote educational opportunities.
In addition, the MOS is committed to support the search for more effective treatments of malignant diseases, work with other organizations and societies that have concerns with cancer care, and disseminate information regarding regulatory developments affecting members.
And finally, the MOS acts as a resource for insurers regarding the standard of care in oncology and represents the practice of oncology and hematology in the State of Mississippi.
MOS is happy to have partnered with NCODA to present their most recent webinars. You can watch all five parts of the COVID-19 series and a special ASCO/NCODA webinar on Patient-Centered Standards for Medically Integrated Dispensing by clicking HERE.
IMPORTANT INFORMATION FOR ALL PROVIDERS FROM THE AMERICAN MEDICAL ASSOCIATION
As of January 1, 2021, there were significant changes to the office and outpatient Evaluation and Management (E&M) services (CPT ® codes 99202-99215) for both new and established patients. Find out more
Updated Recommendations on COVID-19 Vaccine Third Doses from NCCN
The National Comprehensive Cancer Center Network (NCCN), a nonprofit alliance of leading cancer centers, yesterday announced significant updates to the NCCN: Cancer and COVID-19 Vaccination guidance. This is the fourth version of NCCN's COVID-19 vaccination guide and incorporates the latest data plus recent approvals from the FDA and CDC regarding a third mRNA vaccine dose for immunocompromised people. The updated guidance is available for free at NCCN.org/covid-19.
CMS has announced that the federally supported website that makes it easier for individuals to access COVID-19 vaccines is now live. Vaccines.gov – powered by the trusted VaccineFinder brand – is available in English and Spanish, with high accessibility standard, and will help connect Americans with locations offering vaccines near them. In addition to the website, people in the U.S. are also now able to utilize a text message service, available in both English and Spanish. People can text their ZIP code to 438829 (GETVAX) and 822862 (VACUNA) to find three locations nearby that have vaccines available.
Vaccines.gov is meant to complement the number of state and pharmacy websites that have been successfully connecting many Americans with vaccinations, by providing a unified federal resource for Americans to use no matter where they are.
In addition to the website and text messaging service, the National COVID-19 Vaccination Assistance Hotline is now available to help those who prefer to get information by phone on where to get a vaccine. Call 1-800-232-0233 to find a location near you.
STATE CANCER FACT SHEETS AVAILABLE
The 2021 State Cancer Fact Sheets for all fifty states plus the District of Columbia and Puerto Rico are now available on myAffiliates and ASCO’s webpage. The fact sheets contain key cancer and health care data from each state and highlight the impact of NIH funding in your state. These fact sheets are useful background materials for meetings with legislative staff and can aid your advocacy efforts. Contact email@example.com for help with coordinating your advocacy activities.
ASCO Registry The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as, how COVID-19 is impacting the delivery of cancer care and patient outcomes.
ASH Virtual Listening Sessions on Diversity, Equity, and Inclusion The ASH Virtual Listening Sessions on Diversity, Equity, and Inclusion will explore issues facing those from backgrounds traditionally disadvantaged in medicine, as well as DEI opportunities in the hematology community.